# FDA Inspection 1136000 - New York Blood Center Inc - February 24, 2021

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/c6a3e9b1-d717-4cb1-85f7-7ec65954c9a1
Source feed: FDA_Inspections

> FDA Inspection 1136000 for New York Blood Center Inc on February 24, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1136000
- Company Name: New York Blood Center Inc
- Inspection Date: 2021-02-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1294968 - 2025-12-12](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/3e73ca0b-e8d9-4eeb-8684-afa9b38e4a1e)
- [FDA Inspection 1050701 - 2018-05-01](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/e1a2427e-e077-48ef-805d-9526a5e34b67)
- [FDA Inspection 969536 - 2016-05-06](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/2f6969b0-0920-4c9e-a562-cd22d4647181)

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/ffed078a-99a5-4934-961a-8262fee09c76

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d